Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design.

Shridhara Alva¹, Anuj Bhargava², Bruce Bode³, Ronald Brazg⁴, Kristin Castorino⁵, Mark Kipnes⁶, David R Liljenquist⁷, Hien Tran⁸, Hanqing Liu¹, Mohamed Nada¹

¹Abbott Diabetes Care, Alameda, CA, USA.

²Iowa Diabetes, West Des Moines, IA, USA.

³Atlanta Diabetes Associates, Atlanta, GA, USA.

⁴Rainier Clinical Research Center, Renton, WA, USA.

⁵Sansum Diabetes Research Institute, Santa Barbara, CA, USA.

⁶Diabetes & Glandular Disease Clinic, San Antonio, TX, USA.

⁷Rocky Mountain Diabetes Center, Idaho Falls, ID, USA.

⁸Texas Diabetes and Endocrinology, Round Rock, TX, USA.

PubMed PMC DOI PDF

Abstract

BACKGROUND: This study evaluates the performance of a 15-day factory-calibrated continuous glucose monitoring sensor used in FreeStyle Libre 2 Plus (Libre 2 Plus) and FreeStyle Libre 3 Plus (Libre 3 Plus) Systems, featuring an improved sensor design to reduce vitamin C interference. METHODS: Participants aged 2 years and above were enrolled for this study at seven sites in the United States. Depe…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.